Skip to content

DRS. STEVENS-BEIRINCKX

Active
Private limited companyfounded 2001active for 25 yearsKorte Vianenstraat 4, 2300 Turnhout, BelgiumKBO/BCE: BE 0475.942.673
Summary

DRS. STEVENS-BEIRINCKX has been active since 2001 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €2.5m and a net result of €924,890. Equity grew by about 11% per year on average since 2018. In 2025 it fell by 2.5%. Its solvency ranks better than 58% of 3,040 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 25-10-2001 Normal situation
Registered office
14 active companies are registered at this address Source: KBO register, as of 5 November 2026.
Activity
Specialist medical practice NACE 86220and 3 others
Joint committee
330.04 Health institutions and services · annual accounts 2025
Establishment units
2.229.665.754 2300 Turnhout, since 22-10-2001
2.274.802.527 2350 Vosselaar, since 04-04-2018
Financial year end
31 December
Peppol
Reachable since 07-01-2026

Board and ownership

Board
Shareholders
  • Jef Stevensdeed of 18-03-2022
  • An Beirinckxdeed of 18-03-2022

Financial position

93 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€1.7m
▲ 8.4%
Turnover
≈ €1.5m
estimated
Profit
€924,890
▲ 6.3%
Equity
€2.5m
▼ 2.5%
Total assets
€3.6m
▲ 3.6%
Employees on 31-12-2025
3
=
Score breakdownraises riskLiquidity: current ratio 3.17, cash €137,709, halvedlowers riskSector: Human health activities (NACE 86)Size: 2.3 FTE, total assets €3.6mFigures for financial year 2025 (filed on 10-06-2026)Show the evidence

Checked score

Score 2025
93 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 46% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Strong
Solvency 93-4
equity 67.6% of total assets
Liquidity 49-15
short-term debt 19.4% · cash 3.8%
Profitability 100=
return on assets 25.5%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,173 companies, NACE 86, micro)
Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025lowest value 01-2026: < 0.1%● unchanged vs 12-2025lowest value 02-2026: < 0.1%● unchanged vs 01-2026lowest value 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026highest value 08-2026: < 0.1%● unchanged vs 07-2026highest value 09-2026: < 0.1%● unchanged vs 08-2026highest value 10-2026: < 0.1%● unchanged vs 09-2026highest value 11-2026: < 0.1%● unchanged vs 10-2026highest value
Credit of up to €220,000 on 30-day terms is acceptable
Liquidity is ample, with a current ratio of 3.17 (4.77 in 2024), above the usual 1.5. Short-term debt is 19.4% and cash 3.8% of total assets. 32.4% of the assets are financed with debt and provisions.
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 55% of them on solvency, 17% on liquidity, 80% on profitability and 32% on growth.

The bankruptcy probability was computed on 04-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

The probability rests on the annual accounts with balance sheet date 31-12-2025.

Of the companies with a bankruptcy probability in the very low class on 30-06-2025, 0.1% went bankrupt within twelve months.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Five signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Size: 2.3 FTE, total assets €3.6m
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
raises risk · Liquidity: current ratio 3.17, cash €137,709, halved
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed on 10-06-2026)
NBB · annual accounts
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 04-06-2026, 57 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
57 days early
2024
44 days early
2023
75 days early
2022
19 days early
2021
12 days early
2020
130 days early
2019
84 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 60 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 17 June (4 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
05-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Positive: Higher net result than 95% of companies in human healthsector median €110,314 · 3,006 companies €924,890 View
  • Positive: 8 profitable years in a rowprofit 2025: €924,890 8 years View
  • Positive: Filed on time since financial year 2019accounts within the deadline every year 7 years View

Recent changes

  1. · Gazette deed 2 directors resigning, 2 directors reappointedIssue of 86 shares · Resignations: Jef Stevens (director) and An Beirinckx (director) · Reappointments: Jef Stevens (director) and An Beirinckx (director)
  2. · Gazette deed Incorporation
All 15 events

Comparable companies

These companies have the same main activity as DRS. STEVENS-BEIRINCKX: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €2.7m and €5.2m, founded between 2004 and 2009.

CompanyTotal assetsGross margin
DRS. STEVENS-BEIRINCKX Turnhout€3.6m€1.7m
DRS. ZEYEN-COSEMANS Schoten€3.4m€1.4m
DR. M. WIRIX , OPHTALMOLOGIE Hasselt€4.6m€1.3m
DR. MICHEL VAN LOO Schilde€2.7m€1.2m
CABINET MEDICAL DU DOCTEUR GEOFFREY ANCION Theux€4.3m€1.5m
DR. LAMBRECHTS DAVID Brussels€3.1m€1.0m
ST27 Brussels€5.2m€1.2m
Full comparison

Key facts about DRS. STEVENS-BEIRINCKX

What is the company number of DRS. STEVENS-BEIRINCKX?
The company number of DRS. STEVENS-BEIRINCKX is 0475.942.673. The VAT number is the same number with BE in front: BE 0475.942.673.
Where is DRS. STEVENS-BEIRINCKX based?
The registered office is at Korte Vianenstraat 4, 2300 Turnhout.Company details
What does DRS. STEVENS-BEIRINCKX do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of DRS. STEVENS-BEIRINCKX?
DRS. STEVENS-BEIRINCKX is a private limited company (BV).
When was DRS. STEVENS-BEIRINCKX founded?
DRS. STEVENS-BEIRINCKX was founded on 25-10-2001.
Is DRS. STEVENS-BEIRINCKX still active?
Yes, DRS. STEVENS-BEIRINCKX is an active enterprise in the KBO register.
How many employees does DRS. STEVENS-BEIRINCKX have?
DRS. STEVENS-BEIRINCKX had an average of 2.3 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
Which joint committee does DRS. STEVENS-BEIRINCKX fall under?
In its 2025 annual accounts, DRS. STEVENS-BEIRINCKX states joint committee 330.04 (Health institutions and services).
What is the turnover of DRS. STEVENS-BEIRINCKX?
The turnover in financial year 2025 is ≈ €1.5m. This figure is estimated from the gross margin of €1.7m and 64 comparable companies (NACE 86). It probably lies between €1.4m and €2.2m.
Is DRS. STEVENS-BEIRINCKX profitable?
In financial year 2025, DRS. STEVENS-BEIRINCKX made a profit of €924,890.
Where can I find the annual accounts of DRS. STEVENS-BEIRINCKX?
DRS. STEVENS-BEIRINCKX filed 24 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of DRS. STEVENS-BEIRINCKX due?
DRS. STEVENS-BEIRINCKX must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.